FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Anil Sood

Research Profile

Disorders

Living Beings

Anatomy

Tumor Cell Line

Physiology

Chemicals & Drugs

Procedures

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Myrthala Moreno-Smith; Archana S Nagaraja; Masato Nishimura; Ju-Won Roh; Rajesha Rupaimoole; Mian Shahzad; Zahid H Siddik; Julie K Allen; Guillermo N Armaiz; Justin Bottsford-Miller; Steve W Cole; Hee Dong Han; Guangan He; Nicholas B Jennings; Yu Kang; Robert R Langley; Sun Joo Lee; Chunhua Lu; Susan K Lutgendorf; Koji Matsuo; Anil K Sood
Biologic effects of dopamine on tumor vasculature in ovarian carcinoma.
Myrthala Moreno-Smith; Archana S Nagaraja; Cristian Rodriguez-Aguayo; Rajesha Rupaimoole; Rosemarie Schmandt; Zahid H Siddik; Pablo E Vivas-Mejia; Hua Wang; Behrouz Zand; Guillermo N Armaiz; Menashe Bar-Eli; William Bornman; Justin Bottsford-Miller; Jeremy E Coffin; Kshipra M Gharpure; Tamas A Gonda; Jyotsnabaran Halder; Margaret S Halleck; Mary J C Hendrix; Cristina Ivan; Nicholas B Jennings; Yu Kang; Sang Bae Kim; Robert R Langley; Ju Seog Lee; Gabriel Lopez-Berestein; Chunhua Lu; Lingegowda S Mangala; Paul S Meltzer; Anil K Sood
ATP11B mediates platinum resistance in ovarian cancer.
Mian Shahzad; De-Yo Shen; Yong-Hyun Shin; Justin Bottsford-Miller; Wei Hu; Yu Kang; Arvinder Kapur; Gabriel Lopez-Berestein; Chunhua Lu; Koji Matsuo; Edna M Mora; Masato Nishimura; Aleksandar Rajkovic; Cristian Rodriguez-Aguayo; Anil K Sood
Biological significance of HORMA domain containing protein 1 (HORMAD1) in epithelial ovarian carcinoma.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Anil Sood (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2013: Myrthala Moreno-Smith; Archana S Nagaraja; Masato Nishimura; Ju-Won Roh; Rajesha Rupaimoole; Mian Shahzad; Zahid H Siddik; Julie K Allen; Guillermo N Armaiz; Justin Bottsford-Miller; Steve W Cole; Hee Dong Han; Guangan He; Nicholas B Jennings; Yu Kang; Robert R Langley; Sun Joo Lee; Chunhua Lu; Susan K Lutgendorf; Koji Matsuo; Anil K Sood
Biologic effects of dopamine on tumor vasculature in ovarian carcinoma.
Neoplasia (New York, N.Y.) 2013;15(5):502-10.
2013: Myrthala Moreno-Smith; Archana S Nagaraja; Cristian Rodriguez-Aguayo; Rajesha Rupaimoole; Rosemarie Schmandt; Zahid H Siddik; Pablo E Vivas-Mejia; Hua Wang; Behrouz Zand; Guillermo N Armaiz; Menashe Bar-Eli; William Bornman; Justin Bottsford-Miller; Jeremy E Coffin; Kshipra M Gharpure; Tamas A Gonda; Jyotsnabaran Halder; Margaret S Halleck; Mary J C Hendrix; Cristina Ivan; Nicholas B Jennings; Yu Kang; Sang Bae Kim; Robert R Langley; Ju Seog Lee; Gabriel Lopez-Berestein; Chunhua Lu; Lingegowda S Mangala; Paul S Meltzer; Anil K Sood
ATP11B mediates platinum resistance in ovarian cancer.
The Journal of clinical investigation 2013;123(5):2119-30.
2013: Mian Shahzad; De-Yo Shen; Yong-Hyun Shin; Justin Bottsford-Miller; Wei Hu; Yu Kang; Arvinder Kapur; Gabriel Lopez-Berestein; Chunhua Lu; Koji Matsuo; Edna M Mora; Masato Nishimura; Aleksandar Rajkovic; Cristian Rodriguez-Aguayo; Anil K Sood
Biological significance of HORMA domain containing protein 1 (HORMAD1) in epithelial ovarian carcinoma.
Cancer letters 2013;330(2):123-9.
2013: Isaiah Gregory Schauer; Anil K Sood; Zhen Xing; Jing Zhang; Xiaoqing Guo; Peng Huang; Imelda Mercado-Uribe; Jinsong Liu
Interleukin-1β promotes ovarian tumorigenesis through a p53/NF-κB-mediated inflammatory response in stromal fibroblasts.
Neoplasia (New York, N.Y.) 2013;15(4):409-20.
2013: Haifa Shen; Anil K Sood; Rong Xu; Guodong Zhang; Junhua Mai; Guoting Qin; Cristian Rodriguez-Aguayo; Jason Sakamoto; Burcu Aslan; Litao Bai; Arturo Chavez-Reyes; Xiaoyong Deng; Donald R Erm; Mauro Ferrari; Vianey Gonzalez-Villasana; Xiaojing Guo; Hee-Dong Han; Yi Huang; Qingpo Li; Xuewu Liu; Gabriel Lopez-Berestein
Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(7):1806-15.
2013: Cristina Ivan; Tao Liu; Gabriel Lopez-Berestein; Alpa M Nick; Keith A Baggerly; Justin Bottsford-Miller; Robert L Coleman; Heather J Dalton; Wei Hu; Jie Huang; Behrouz Zand; Anil K Sood
Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer.
Gynecologic oncology 2013;128(3):506-11.
2013: Andrew Schrepf; George M Slavich; Anil K Sood; Premal H Thaker; Kristian Markon; Luis Mendez; Frank J Penedo; Amina Ahmed; David Bender; Desire Christensen; Lauren Clevenger; Laila Dahmoush; Koen DeGeest; Parvin Ganjei-Azar; Michael J Goodheart; David M Lubaroff; Joseph Lucci; Susan K Lutgendorf
Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability.
Brain, behavior, and immunity 2013;30 Suppl():S126-34.
2013: Guillermo N Armaiz-Pena; Steve W Cole; Susan K Lutgendorf; Anil K Sood
Neuroendocrine influences on cancer progression.
Brain, behavior, and immunity 2013;30 Suppl():S19-25.
2013: Da Yang; Yanrui Zhao; Hong Zheng; Russell Broaddus; Kexin Chen; Hanyin Cheng; David Cogdell; Limei Hu; Ping Ji; Jinsong Liu; Gabriel Lopez-Berestein; Matti Nykter; Chad V Pecot; Sheila Reynolds; Cristian Rodriguez-Aguayo; Rajesha Rupaimoole; Ilya Shmulevich; Anil K Sood; Yan Sun; Wei Zhang
Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer.
Cancer cell 2013;23(2):186-99.
2013: Takahito M Miyake; Anil K Sood; Robert L Coleman
Contemporary use of bevacizumab in ovarian cancer.
Expert opinion on biological therapy 2013;13(2):283-94.
2013: Angela J Ziebarth; Michael Conner; Zachary C Dobbin; Hee-Dong Han; Ashwini A Katre; Gabriel Lopez-Berestein; Somaira Nowsheen; Monjri M Shah; Anil K Sood; Adam D Steg; Eddy S Yang; Charles N Landen
Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(1):170-82.
2012: Justin N Bottsford-Miller; Robert L Coleman; Anil K Sood
Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(32):4026-34.
2012: Koji Matsuo; Takahito Miyake; Takayuki Enomoto; Karina E Hew; Dwight D Im; Tadashi Kimura; Seiji Mabuchi; Neil B Rosenshein; Todd B Sheridan; Anil K Sood; Kiyoshi Yoshino; Lynda D Roman
Significance of lymphovascular space invasion in epithelial ovarian cancer.
Cancer medicine 2012;1(2):156-64.
2012: Guoyan Liu; Ilya Shmulevich; Anil K Sood; Yan Sun; Fengxia Xue; Da Yang; Wei Zhang
Differing clinical impact of BRCA1 and BRCA2 mutations in serous ovarian cancer.
Pharmacogenomics 2012;13(13):1523-35.
2012: Yun-Yong Park; Guang Peng; Cristian Rodriguez-Aguayo; Anil K Sood; Nicholas B Jennings; Sung Yun Jung; KYOUNGHYUN Kim; Sang Bae Kim; Se-Ran Lee; Sun-Hee Leem; Shiaw-Yih Lin; Gabriel Lopez-Berestein; Ju Seog Lee
FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair.
Carcinogenesis 2012;33(10):1843-53.
2012: Lauren Clevenger; Koen DeGeest; Michael J Goodheart; David M Lubaroff; Amina Ahmed; David Bender; Desire Christensen; Frank J Penedo; Andrew Schrepf; Anil K Sood; Susan K Lutgendorf
Sleep disturbance, cytokines, and fatigue in women with ovarian cancer.
Brain, behavior, and immunity 2012;26(7):1037-44.
2012: Siqing Fu; David M Gershenson; Zhen Hong; Jie Huang; John J Kavanagh; Yanfang Li; Tao Liu; Anil K Sood; Robert C Bast; Aiping Chen; Wei Hu
Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3.
Cancer biology & therapy 2012;13(11):1034-41.
2012: Susan K Lutgendorf; Luis Mendez; Frank J Penedo; George M Slavich; Premal H Thaker; M Bridget Zimmerman; Amina Ahmed; David Bender; Steve W Cole; Laila Dahmoush; Koen De Geest; Parvin Ganjei-Azar; Michael J Goodheart; David M Lubaroff; Joseph Lucci; Anil K Sood
Social influences on clinical outcomes of patients with ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(23):2885-90.
2012: Sun Joo Lee; Alejandro Lopez-Araujo; Chunhua Lu; Masato Nishimura; Chad V Pecot; De Yue Shen; Rebecca L Stone; Duangmani Thanapprapasr; Behrouz Zand; Edmond J Auzenne; Justin Bottsford-Miller; Sukhen C Ghosh; Hee Dong Han; Wei Hu; Jie Huang; Nicholas B Jennings; Yu Kang; Jim Klostergaard; Anil K Sood
Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(15):4114-21.
2012: Siqing Fu; David M Gershenson; Bryan T Hennessy; Adrienne Howard; Ed Jackson; Zhenlin Ju; John J Kavanagh; Vikas Kundra; Razelle Kurzrock; Charles F Levenback; Jane Li; Yang Li; Maurie Markman; Edward Atkinson; Robert C Bast; Robert L Coleman; Kevin R Coombes; Kristine Dice; Mary Dyer; Chaan S Ng; Anil K Sood; Katherine Stemke-Hale; Judith K Wolf; Gordon B Mills
Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer.
Gynecologic oncology 2012;126(1):47-53.
2012: Diane C Bodurka; Robert L Coleman; Michael T Deavers; Robert E Emerson; Rebecca Baergen; Behnaz Behmaram; Michael J Birrer; Karen H Lu; Anais Malpica; Robert Ozols; Golnar Rasty; Anil K Sood; Margaret Steinhoff; Charlotte C Sun; Chunqiao Tian; David M Gershenson
Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study.
Cancer 2012;118(12):3087-94.
2012: Behrouz Zand; Robert L Coleman; Anil K Sood
Targeting angiogenesis in gynecologic cancers.
Hematology/oncology clinics of North America 2012;26(3):543-63, viii.
2012: Jean-Pierre Gillet; Suresh V Ambudkar; Mari Bunkholt Elstrand; Anna Maria Calcagno; Ben Davidson; Ram Ganapathi; Aparna A Kamat; Bo R Rueda; Michael Seiden; Anil K Sood; Sudhir Varma; Michael M Gottesman
Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(11):3197-206.
2012: Kathleen M Schmeler; Yukio Sonoda; Anil K Sood; David M Gershenson; Pedro T Ramirez; Richard R Barakat; Katherine Marie Bell-McGuinn; Robert L Coleman; Michael Frumovitz; Ginger J Gardner
Proceedings from the 9th International Conference on Ovarian Cancer.
Gynecologic oncology 2012;125(1):5-7.
2012: Jessica L Berger; Bryan Fellman; Michael Frumovitz; Vijayashri Rallapali; Pedro T Ramirez; Anil K Sood; Shannon N Westin; Pamela T Soliman
Modified vertical rectus abdominis myocutaneous flap vaginal reconstruction: an analysis of surgical outcomes.
Gynecologic oncology 2012;125(1):252-5.
2012: Jian You; Guodong Zhang; Rui Zhang; Meng Zhong; Dong Liang; Yang Liu; Anil K Sood; Carolyn S Van Pelt; Wei Wei; Chun Li
Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: A platform for near-infrared light-trigged drug release.
Journal of controlled release : official journal of the Controlled Release Society 2012;158(2):319-28.
2012: Steve W Cole; Anil K Sood
Molecular pathways: beta-adrenergic signaling in cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(5):1201-6.
2012: Sherry Y Wu; Anil K Sood
New roles opined for OPCML.
Cancer discovery 2012;2(2):115-6.
2012: Anil K Sood; Robert L Coleman; Lee M Ellis
Moving beyond anti-vascular endothelial growth factor therapy in ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(4):345-7.
2012: Ibrahim Tekedereli; Ibrahim Sahin; Anil K Sood; Clint D J Tavares; S Neslihan Alpay; Zehra E Cobanoglu; Kevin N Dalby; Tamer S Kaoud; Gabriel Lopez-Berestein; Bulent Ozpolat
Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer.
PloS one 2012;7(7):e41171.
2012: Lorenzo Cohen; Steve W Cole; Nicholas B Jennings; Eric Jonasch; Diane Kentor; Clemens Kirschbaum; Jesusa M Arevalo; Sarah Prinsloo; Laszlo G Radvanyi; Shellie Scott; Anil K Sood; Pheroze Tamboli; Nizar Tannir; Luis Vence; Qi Wei; Louis Pisters
Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: role of inflammatory signaling.
PloS one 2012;7(8):e42324.
2012: Yuexin Liu; Ilya Shmulevich; Anil K Sood; Yan Sun; Russell Broaddus; Jinsong Liu; Wei Zhang
Integrated analysis of gene expression and tumor nuclear image profiles associated with chemotherapy response in serous ovarian carcinoma.
PloS one 2012;7(5):e36383.
2012: Duangmani Thanapprapasr; Wei Hu; Anil K Sood; Robert L Coleman
Moving beyond VEGF for anti-angiogenesis strategies in gynecologic cancer.
Current pharmaceutical design 2012;18(19):2713-9.
2011: Alpa M Nick; Bulent Ozpolat; Prahlad T Ram; Rebecca L Stone; Ibrahim Tekedereli; Gabriel Villares; Pablo Vivas-Mejia; Guillermo N Armaiz-Pena; Keith A Baggerly; Justin Bottsford-Miller; Robert L Coleman; Michael T Deavers; Whitney S Graybill; Hye Sun Kim; Soo Mi Kim; Charles N Landen; Ju Seog Lee; Gabriel Lopez-Berestein; Anil K Sood
Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death.
Journal of the National Cancer Institute 2011;103(21):1596-612.
2011: Susan K Lutgendorf; Anil K Sood
Biobehavioral factors and cancer progression: physiological pathways and mechanisms.
Psychosomatic medicine 2011;73(9):724-30.
2011: Robert L Coleman; Linda R Duska; Michael E Garcia; John V Heymach; Revathy B Iyer; Edward F Jackson; Robert Jaffe; Aparna A Kamat; Vikas Kundra; Debbie L Miller; Susan C Modesitt; Chaan S Ng; Pedro T Ramirez; Kathleen M Schmeler; Anil K Sood
Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer.
The lancet oncology 2011;12(12):1109-17.
2011: Puja Gaur; Gabriel Lopez-Berestein; Jia Lu; Asif Rashid; Shaija Samuel; Eric L Sceusi; Anil K Sood; Federico Tozzi; Jean-Nicolas Vauthey; Pablo Vivas-Mejia; Ling Xia; James C Yao; Yunfei Zhou; Eddie K Abdalla; Steven A Curley; Fan Fan; Jason B Fleming; Lee M Ellis
Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors.
Gastroenterology 2011;141(5):1728-37.
2011: Da Yang; Kenneth Hess; Sofia Khan; Ilya Shmulevich; Anil K Sood; Yan Sun; Wei Zhang
Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer.
JAMA : the journal of the American Medical Association 2011;306(14):1557-65.
2011: Adam D Steg; Rebecca L Stone; Gabriel Lopez-Berestein; Alpa M Nick; Anil K Sood; Ronald D Alvarez; Robert L Coleman; Blake Goodman; Hee-Dong Han; Ashwini A Katre; Charles N Landen
Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(17):5674-85.
2011: Koji Matsuo; Tadayoshi Nagano; Masato Nishimura; Prahlad T Ram; Neil B Rosenshien; Ju Won Roh; Atsuko Sakakibara; Angela M Sanguino; Kathleen M Schmeler; Mian Shahzad; Guillermo N Armaiz-Pena; Justin N Bottsford-Miller; Takayuki Enomoto; Michael Frumovitz; Gary E Gallick; Jie Huang; Dwight D Im; Tadashi Kimura; Kakajan Komurov; Chunhua Lu; Rebecca L Stone; Kwong K Wong; Masato Yamasaki; Anil K Sood
Targeting SRC in mucinous ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(16):5367-78.
2011: Amal Melhem-Bertrandt; Funda Meric-Bernstam; Anil K Sood; Gabriel N Hortobagyi; Richard T Lee; Xiudong Lei; Erika N Brown; Mariana Chavez-Macgregor; Suzanne D Conzen; Ana-Maria Gonzalez-Angulo
Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(19):2645-52.
2011: Rajesha Rupaimoole; Hee-Dong Han; Gabriel Lopez-Berestein; Anil K Sood
MicroRNA therapeutics: principles, expectations, and challenges.
Chinese journal of cancer 2011;30(6):368-70.
2011: Myrthala Moreno-Smith; Guillermo N Armaiz Pena; Mian Shahzad; Rebecca L Stone; Julie K Allen; Gabriel Lopez Berestein; Steve W Cole; Donna Farley; Hee Dong Han; Hye Sun Kim; Chunhua Lu; Susan K Lutgendorf; Lingegowda S Mangala; Anil K Sood
Dopamine blocks stress-mediated ovarian carcinoma growth.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(11):3649-59.
2011: Pablo E Vivas-Mejia; Arturo Chavez-Reyes; Hee-Dong Han; Cristian Rodriguez-Aguayo; Mian Shahzad; Mineko Shibayama; Anil K Sood; Fatma Valiyeva; Gabriel Lopez-Berestein
Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(11):3716-26.
2011: Isaiah G Schauer; Anil K Sood; Samuel C Mok; Jinsong Liu
Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer.
Neoplasia (New York, N.Y.) 2011;13(5):393-405.
2011: Hee Dong Han; Edna M Mora; Ju Won Roh; Masato Nishimura; Sun Joo Lee; Rebecca L Stone; Menashe Bar-Eli; Gabriel Lopez-Berestein; Anil K Sood
Chitosan hydrogel for localized gene silencing.
Cancer biology & therapy 2011;11(9):839-45.
2011: Siqing Fu; Wei Hu; Revathy Iyer; John J Kavanagh; Robert L Coleman; Charles F Levenback; Anil K Sood; Judith K Wolf; David M Gershenson; Maurie Markman; Bryan T Hennessy; Razelle Kurzrock; Robert C Bast
Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer.
Cancer 2011;117(8):1661-9.
2011: Mian Shahzad; Lingegowda S Mangala; Hee Dong Han; Chunhua Lu; Justin Bottsford-Miller; Masato Nishimura; Edna M Mora; Jeong-Won Lee; Rebecca L Stone; Chad V Pecot; Duangmani Thanapprapasr; Ju-Won Roh; Puja Gaur; Maya P Nair; Yun-Yong Park; Nirupama Sabnis; Michael T Deavers; Ju Seog Lee; Lee M Ellis; Gabriel Lopez-Berestein; Walter J McConathy; Laszlo Prokai; Andras G Lacko; Anil K Sood
Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles.
Neoplasia (New York, N.Y.) 2011;13(4):309-19.
2011: Anil K Sood; Susan K Lutgendorf
Stress influences on anoikis.
Cancer prevention research (Philadelphia, Pa.) 2011;4(4):481-5.
2011: Hye-Sun Kim; Hee Dong Han; Guillermo N Armaiz-Pena; Rebecca L Stone; Eun Ji Nam; Jeong-Won Lee; Mian Shahzad; Alpa M Nick; Sun Joo Lee; Ju-Won Roh; Masato Nishimura; Lingegowda S Mangala; Justin Bottsford-Miller; Gary E Gallick; Gabriel Lopez-Berestein; Anil K Sood
Functional roles of Src and Fgr in ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(7):1713-21.
2011: Anil K Sood; Marsha T Wilson; Thomas J Herzog
Supporting gynecologic cancer research: the last 20 years and beyond.
Gynecologic oncology 2011;120(3):319-20.
2011: Donald M Lamkin; Susan K Lutgendorf; David M Lubaroff; Anil K Sood; Terry G Beltz; Alan Kim Johnson
Cancer induces inflammation and depressive-like behavior in the mouse: modulation by social housing.
Brain, behavior, and immunity 2011;25(3):555-64.
2011: Erin S Costanzo; Anil K Sood; Susan K Lutgendorf
Biobehavioral influences on cancer progression.
Immunology and allergy clinics of North America 2011;31(1):109-32.
2011: Shaija Samuel; Anil K Sood; Ling Xia; Anil Bagri; Debashish Bose; Nikolaos A Dallas; Fan Fan; Puja Gaur; Michael J Gray; Gabriel Lopez-Berestein; Greg Plowman; Cristian Rodriguez-Aguayo; Lee M Ellis
Neuropilin-2 mediated β-catenin signaling and survival in human gastro-intestinal cancer cell lines.
PloS one 2011;6(10):e23208.
2011: Amy R Carroll; Robert L Coleman; Anil K Sood
Therapeutic advances in women's cancers.
Frontiers in bioscience (Scholar edition) 2011;3():82-97.
2011: Chad V Pecot; George A Calin; Robert L Coleman; Gabriel Lopez-Berestein; Anil K Sood
RNA interference in the clinic: challenges and future directions.
Nature reviews. Cancer 2011;11(1):59-67.
2010: William M Merritt; Aparna A Kamat; Jee-Young Hwang; Justin Bottsford-Miller; Chunhua Lu; Yvonne G Lin; Donna Coffey; Whitney A Spannuth; Elizabeth Nugent; Liz Y Han; Charles N Landen; Alpa M Nick; Rebecca L Stone; Karen Coffman; Elizabeth M Bruckheimer; Russell R Broaddus; David M Gershenson; Robert L Coleman; Anil K Sood
Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer.
Cancer biology & therapy 2010;10(12):1306-14.
2010: Myrthala Moreno-Smith; Susan K Lutgendorf; Anil K Sood
Impact of stress on cancer metastasis.
Future oncology (London, England) 2010;6(12):1863-81.
2010: Charles N Landen; Blake Goodman; Ashwini A Katre; Adam D Steg; Alpa M Nick; Rebecca L Stone; Lance D Miller; Pablo Vivas Mejia; Nicolas B Jennings; David M Gershenson; Robert C Bast; Robert L Coleman; Gabriel Lopez-Berestein; Anil K Sood
Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer.
Molecular cancer therapeutics 2010;9(12):3186-99.
2010: Shu Feng; Irina U Agoulnik; Anne Truong; Zhen Li; Chad J Creighton; Elena M Kaftanovskaya; Rhea Pereira; Hee Dong Han; Gabriel Lopez-Berestein; Thomas Klonisch; Michael Ittmann; Anil K Sood; Alexander I Agoulnik
Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis.
Endocrine-related cancer 2010;17(4):1021-33.
2010: Mian Shahzad; Jesusa M Arevalo; Guillermo N Armaiz-Pena; Chunhua Lu; Rebecca L Stone; Myrthala Moreno-Smith; Masato Nishimura; Jeong-Won Lee; Nicholas B Jennings; Justin Bottsford-Miller; Pablo Vivas-Mejia; Susan K Lutgendorf; Gabriel Lopez-Berestein; Menashe Bar-Eli; Steve W Cole; Anil K Sood
Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis.
The Journal of biological chemistry 2010;285(46):35462-70.
2010: Koji Matsuo; Yvonne G Lin; Lynda D Roman; Anil K Sood
Overcoming platinum resistance in ovarian carcinoma.
Expert opinion on investigational drugs 2010;19(11):1339-54.
2010: Jubilee Brown; Judith A Smith; Lois M Ramondetta; Anil K Sood; Pedro T Ramirez; Robert L Coleman; Charles Levenback; Mark F Munsell; Maria Jung; Judith K Wolf
Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial.
Cancer 2010;116(21):4973-9.
2010: Susan K Lutgendorf; Elizabeth Mullen-Houser; Daniel Russell; Koen DeGeest; Geraldine Jacobson; Laura Hart; David Bender; Barrie Anderson; Thomas E Buekers; Michael J Goodheart; Michael H Antoni; Anil K Sood; David M Lubaroff
Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approach.
Brain, behavior, and immunity 2010;24(8):1231-40.
2010: Aliza Z Weinrib; Sandra E Sephton; Koen DeGeest; Frank J Penedo; David Bender; Bridget Zimmerman; Clemens Kirschbaum; Anil K Sood; David M Lubaroff; Susan K Lutgendorf
Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer.
Cancer 2010;116(18):4410-9.
2010: Whitney A Spannuth; Lingegowda S Mangala; Rebecca L Stone; Amy R Carroll; Masato Nishimura; Mian Shahzad; Sun-Joo Lee; Myrthala Moreno-Smith; Alpa M Nick; Ren Liu; Nicholas B Jennings; Yvonne G Lin; William M Merritt; Robert L Coleman; Pablo E Vivas-Mejia; Yue Zhou; Valery Krasnoperov; Gabriel Lopez-Berestein; parkash Gill; Anil K Sood
Converging evidence for efficacy from parallel EphB4-targeted approaches in ovarian carcinoma.
Molecular cancer therapeutics 2010;9(8):2377-88.
2010: Kathleen M Schmeler; Xia Tao; Michael Frumovitz; Michael T Deavers; Charlotte C Sun; Anil K Sood; Jubilee Brown; David M Gershenson; Pedro T Ramirez
Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovary.
Obstetrics and gynecology 2010;116(2 Pt 1):269-73.
2010: Hee Dong Han; Lingegowda S Mangala; Jeong Won Lee; Mian Shahzad; Hye Sun Kim; Deyu Shen; Eun Ji Nam; Edna M Mora; Rebecca L Stone; Chunhua Lu; Sun Joo Lee; Ju Won Roh; Alpa M Nick; Gabriel Lopez-Berestein; Anil K Sood
Targeted gene silencing using RGD-labeled chitosan nanoparticles.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(15):3910-22.
2010: Michael Frumovitz; Kathleen M Schmeler; Anais Malpica; Anil K Sood; David M Gershenson
Unmasking the complexities of mucinous ovarian carcinoma.
Gynecologic oncology 2010;117(3):491-6.
2010: Takemi Tanaka; Lingegowda S Mangala; Pablo E Vivas-Mejia; René Nieves-Alicea; Aman P Mann; Edna Mora; Hee-Dong Han; Mian Shahzad; Xuewu Liu; Rohan Bhavane; Jianhua Gu; Jean R Fakhoury; Ciro Chiappini; Chunhua Lu; Koji Matsuo; Biana Godin; Rebecca L Stone; Alpa M Nick; Gabriel Lopez-Berestein; Anil K Sood; Mauro Ferrari
Sustained small interfering RNA delivery by mesoporous silicon particles.
Cancer research 2010;70(9):3687-96.
2010: Anil K Sood; Guillermo N Armaiz-Pena; Jyotsnabaran Halder; Alpa M Nick; Rebecca L Stone; Wei Hu; Amy R Carroll; Whitney A Spannuth; Michael T Deavers; Julie K Allen; Liz Y Han; Aparna A Kamat; Mian Shahzad; Bradley W McIntyre; Claudia Diaz; Nicholas B Jennings; Yvonne G Lin; William M Merritt; Koen DeGeest; Pablo E Vivas-Mejia; Gabriel Lopez-Berestein; Michael D Schaller; Steve W Cole; Susan K Lutgendorf
Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis.
The Journal of clinical investigation 2010;120(5):1515-23.
2010: Jeong-Won Lee; Rebecca L Stone; Sun Joo Lee; Eun Ji Nam; Ju-Won Roh; Alpa M Nick; Hee-Dong Han; Mian Shahzad; Hye-Sun Kim; Lingegowda S Mangala; Nicholas B Jennings; Shenlan Mao; John Gooya; Dowdy Jackson; Robert L Coleman; Anil K Sood
EphA2 targeted chemotherapy using an antibody drug conjugate in endometrial carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(9):2562-70.
2010: Rebecca L Stone; Anil K Sood; Robert L Coleman
Collateral damage: toxic effects of targeted antiangiogenic therapies in ovarian cancer.
The lancet oncology 2010;11(5):465-75.
2010: Aparna A Kamat; Mathew Baldwin; Diana Urbauer; Diana Dang; Liz Y Han; Andrew Godwin; Beth Y Karlan; Joe Simpson; David M Gershenson; Robert L Coleman; Farideh Z Bischoff; Anil K Sood
Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker.
Cancer 2010;116(8):1918-25.
2010: William M Merritt; Alpa M Nick; Amy R Carroll; Chunhua Lu; Koji Matsuo; Melissa Dumble; Nicholas B Jennings; Shuyun Zhang; Yvonne G Lin; Whitney A Spannuth; Aparna A Kamat; Rebecca L Stone; Mian Shahzad; Robert L Coleman; Rakesh Kumar; Anil K Sood
Bridging the gap between cytotoxic and biologic therapy with metronomic topotecan and pazopanib in ovarian cancer.
Molecular cancer therapeutics 2010;9(4):985-95.
2010: William M Merritt; Menashe Bar-Eli; Anil K Sood
The dicey role of Dicer: implications for RNAi therapy.
Cancer research 2010;70(7):2571-4.
2010: Whitney A Spannuth; Anil K Sood; Robert L Coleman
Farletuzumab in epithelial ovarian carcinoma.
Expert opinion on biological therapy 2010;10(3):431-7.
2010: Kathleen M Schmeler; Anuja Jhingran; Revathy B Iyer; Charlotte C Sun; Patricia J Eifel; Pamela T Soliman; Pedro T Ramirez; Michael Frumovitz; Diane C Bodurka; Anil K Sood
Pelvic fractures after radiotherapy for cervical cancer: implications for survivors.
Cancer 2010;116(3):625-30.
2010: Chunhua Lu; Mian Shahzad; Myrthala Moreno-Smith; Yvonne G Lin; Nicholas B Jennings; Julie K Allen; Charles N Landen; Lingegowda S Mangala; Guillermo N Armaiz-Pena; Rosemarie Schmandt; Alpa M Nick; Rebecca L Stone; Robert B Jaffe; Robert L Coleman; Anil K Sood
Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models.
Cancer biology & therapy 2010;9(3):176-82.
2010: Jie Huang; Wei Hu; Anil K Sood
Prognostic biomarkers in ovarian cancer.
Cancer biomarkers : section A of Disease markers 2010;8(4-5):231-51.
2010: Aman P Mann; Anoma Somasunderam; René Nieves-Alicea; Xin Li; Austin Hu; Anil K Sood; Mauro Ferrari; David Gorenstein; Takemi Tanaka
Identification of thioaptamer ligand against E-selectin: potential application for inflamed vasculature targeting.
PloS one 2010;5(9):.
2010: Bulent Ozpolat; Anil K Sood; Gabriel Lopez-Berestein
Nanomedicine based approaches for the delivery of siRNA in cancer.
Journal of internal medicine 2010;267(1):44-53.
2010: Pablo Vivas-Mejia; Juliana Maria Benito; Ariel Fernandez; Hee-Dong Han; Lingegowda Mangala; Cristian Rodriguez-Aguayo; Arturo Chavez-Reyes; Yvonne G Lin; Mark S Carey; Alpa M Nick; Rebecca L Stone; Hye Sun Kim; Francois Claret; William G Bornmann; Bryan T. J. Hennessy; Angela M Sanguino; Zhengong Peng; Anil K Sood; Gabriel Lopez-Berestein
c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(1):184-94.
2009: Tae Jin Kim; Charles N Landen; Yvonne G Lin; Lingegowda S Mangala; Chunhua Lu; Alpa M Nick; Rebecca L Stone; William M Merritt; Guillermo Armaiz-Pena; Nicholas B Jennings; Robert L Coleman; David A Tice; Anil K Sood
Combined anti-angiogenic therapy against VEGF and integrin alphaVbeta3 in an orthotopic model of ovarian cancer.
Cancer biology & therapy 2009;8(23):2263-72.
2009: Mian Shahzad; Gabriel Lopez-Berestein; Anil K Sood
Novel strategies for reversing platinum resistance.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2009;12(6):148-52.
2009: You-Qing Cai; Shao-Rui Chen; Hee-Dong Han; Anil K Sood; Gabriel Lopez-Berestein; Hui-Lin Pan
Role of M2, M3, and M4 muscarinic receptor subtypes in the spinal cholinergic control of nociception revealed using siRNA in rats.
Journal of neurochemistry 2009;111(4):1000-10.
2009: Jeong-Won Lee; Hee Dong Han; Mian Shahzad; Seung Wook Kim; Lingegowda S Mangala; Alpa M Nick; Chunhua Lu; Robert R Langley; Rosemarie Schmandt; Hye-Sun Kim; Shenlan Mao; John Gooya; Christine A Fazenbaker; Dowdy Jackson; David A Tice; Charles N Landen; Robert L Coleman; Anil K Sood
EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma.
Journal of the National Cancer Institute 2009;101(17):1193-205.
2009: Xia Tao; Anil K Sood; Michael T Deavers; Kathleen M Schmeler; Alpa M Nick; Robert L Coleman; Ljiljana Milojevic; David M Gershenson; Jubilee Brown
Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors.
Gynecologic oncology 2009;114(3):431-6.
2009: William M Merritt; Christopher G Danes; Mian Shahzad; Yvonne G Lin; Aparna A Kamat; Liz Y Han; Whitney A Spannuth; Alpa M Nick; Lingegowda S Mangala; Rebecca L Stone; Hye Sun Kim; David M Gershenson; Robert B Jaffe; Robert L Coleman; Joya Chandra; Anil K Sood
Anti-angiogenic properties of metronomic topotecan in ovarian carcinoma.
Cancer biology & therapy 2009;8(16):1596-603.
2009: David M Gershenson; Charlotte C Sun; Diane C Bodurka; Robert L Coleman; Karen H Lu; Anil K Sood; Michael Deavers; Anais L Malpica; John J Kavanagh
Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant.
Gynecologic oncology 2009;114(1):48-52.
2009: Aparna A Kamat; Donna Coffey; William M Merritt; Elizabeth Nugent; Diana Urbauer; Yvonne G Lin; Creighton Edwards; Russell R Broaddus; Robert L Coleman; Anil K Sood
EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer.
Cancer 2009;115(12):2684-92.
2009: John W Moroney; Anil K Sood; Robert L Coleman
Aflibercept in epithelial ovarian carcinoma.
Future oncology (London, England) 2009;5(5):591-600.
2009: Lingegowda S Mangala; Vesna Zuzel; Rosemarie Schmandt; Erik S LeShane; Jyotsnabaran Halder; Guillermo N Armaiz-Pena; Whitney A Spannuth; Takemi Tanaka; Mian Shahzad; Yvonne G Lin; Alpa M Nick; Christopher G Danes; Jeong-Won Lee; Nicholas B Jennings; Pablo E Vivas-Mejia; Judith K Wolf; Robert L Coleman; Zahid H Siddik; Gabriel Lopez-Berestein; Svetlana Lutsenko; Anil K Sood
Therapeutic Targeting of ATP7B in Ovarian Carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(11):3770-80.
2009: Mian Shahzad; Chunhua Lu; Jeong-Won Lee; Rebecca L Stone; Rahul Mitra; Lingegowda S Mangala; Yiling Lu; Keith A Baggerly; Christopher G Danes; Alpa M Nick; Jyotsnabaran Halder; Hye-Sun Kim; Pablo Vivas-Mejia; Charles N Landen; Gabriel Lopez-Berestein; Robert L Coleman; Anil K Sood
Dual targeting of EphA2 and FAK in ovarian carcinoma.
Cancer biology & therapy 2009;8(11):1027-34.
2009: Guillermo N Armaiz-Pena; Lingegowda S Mangala; Whitney A Spannuth; Yvonne G Lin; Nicholas B Jennings; Alpa M Nick; Robert R Langley; Rosemarie Schmandt; Susan K Lutgendorf; Steve W Cole; Anil K Sood
Estrous cycle modulates ovarian carcinoma growth.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(9):2971-8.
2009: Jeong-Won Lee; Mian Shahzad; Yvonne G Lin; Guillermo N Armaiz-Pena; Lingegowda S Mangala; Hee-Dong Han; Hye-Sun Kim; Eun Ji Nam; Nicholas B Jennings; Jyotsnabaran Halder; Alpa M Nick; Rebecca L Stone; Chunhua Lu; Susan K Lutgendorf; Steve W Cole; Anna Lokshin; Anil K Sood
Surgical stress promotes tumor growth in ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(8):2695-702.
2009: Jubilee Brown; Anil K Sood; Michael T Deavers; Ljiljana Milojevic; David M Gershenson
Patterns of metastasis in sex cord-stromal tumors of the ovary: can routine staging lymphadenectomy be omitted?
Gynecologic oncology 2009;113(1):86-90.
2009: Donald M Lamkin; Douglas R Spitz; Mian Shahzad; Bridget Zimmerman; Daniel J Lenihan; Koen DeGeest; David M Lubaroff; Eileen H Shinn; Anil K Sood; Susan K Lutgendorf
Glucose as a prognostic factor in ovarian carcinoma.
Cancer 2009;115(5):1021-7.
2009: Susan K Lutgendorf; Koen DeGeest; Caroline Y Sung; Jesusa M Arevalo; Frank J Penedo; Joseph Lucci; Michael Goodheart; David M Lubaroff; Donna M Farley; Anil K Sood; Steve W Cole
Depression, social support, and beta-adrenergic transcription control in human ovarian cancer.
Brain, behavior, and immunity 2009;23(2):176-83.
2009: Vijaya Ramachandran; Thiruvengadam Arumugam; Robert Langley; Rosa F Hwang; Pablo Vivas-Mejia; Anil K Sood; Gabriel Lopez-Berestein; Craig D Logsdon
The ADMR receptor mediates the effects of adrenomedullin on pancreatic cancer cells and on cells of the tumor microenvironment.
PloS one 2009;4(10):e7502.
2009: Lingegowda S Mangala; Hee Dong Han; Gabriel Lopez-Berestein; Anil K Sood
Liposomal siRNA for ovarian cancer.
Methods in molecular biology (Clifton, N.J.) 2009;555():29-42.
2009: Guillermo N Armaiz-Pena; Susan K Lutgendorf; Steve W Cole; Anil K Sood
Neuroendocrine modulation of cancer progression.
Brain, behavior, and immunity 2009;23(1):10-5.
2008: Michael J Gray; N A Dallas; George van Buren; L Xia; Anthony D Yang; Ray Somcio; P Gaur; Lingegowda S Mangala; P E Vivas-Mejia; Fan Fan; Angela M Sanguino; Gary E Gallick; Gabriel Lopez-Berestein; Anil K Sood; Lee M Ellis
Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver.
Oncogene 2008;27(57):7192-200.
2008: Susan K Lutgendorf; Donald M Lamkin; Nicholas B Jennings; Jesusa M G Arevalo; Frank J Penedo; Koen DeGeest; Robert R Langley; Joseph Lucci; Steve W Cole; David M Lubaroff; Anil K Sood
Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(21):6839-46.
2008: Gabriel J Villares; Maya Zigler; Hua Wang; Vladislava O Melnikova; Hong Wu; Ran Friedman; Michael C Leslie; Pablo E Vivas-Mejia; Gabriel Lopez-Berestein; Anil K Sood; Menashe Bar-Eli
Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA.
Cancer research 2008;68(21):9078-86.
2008: Charles N Landen; Tae-Jin Kim; Yvonne G Lin; William M Merritt; Aparna A Kamat; Liz Y Han; Whitney A Spannuth; Alpa M Nick; Nicholas B Jennnings; Michael S Kinch; David A Tice; Anil K Sood
Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer.
Neoplasia (New York, N.Y.) 2008;10(11):1259-67.
2008: Susan K Lutgendorf; Aliza Z Weinrib; Frank J Penedo; Daniel Russell; Koen DeGeest; Erin S Costanzo; Patrick J Henderson; Sandra E Sephton; Nicolas Rohleder; Joseph Lucci; Steven Cole; Anil K Sood; David M Lubaroff
Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(29):4820-7.
2008: Alpa M Nick; Anil K Sood
The ROC 'n' role of the multiplex assay for early detection of ovarian cancer.
Nature clinical practice. Oncology 2008;5(10):568-9.
2008: Yvonne G Lin; Anand Immaneni; William M Merritt; Lingegowda S Mangala; Seung Wook Kim; Mian Shahzad; Yvonne T M Tsang; Guillermo N Armaiz-Pena; Chunhua Lu; Aparna A Kamat; Liz Y Han; Whitney A Spannuth; Alpa M Nick; Charles N Landen; Kwong K Wong; Michael J Gray; Robert L Coleman; Diane C Bodurka; William R Brinkley; Anil K Sood
Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(17):5437-46.
2008: Susan K Lutgendorf; Donald M Lamkin; Koen DeGeest; Barrie Anderson; Minh Dao; Stephanie McGinn; Bridget Zimmerman; Heena Maiseri; Anil K Sood; David M Lubaroff
Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients.
Brain, behavior, and immunity 2008;22(6):890-900.
2008: Jee Young Hwang; Lingegowda S Mangala; Jansina Y Fok; Yvonne G Lin; William M Merritt; Whitney A Spannuth; Alpa M Nick; Derek J Fiterman; Pablo E Vivas-Mejia; Michael T Deavers; Robert L Coleman; Gabriel Lopez-Berestein; Kapil Mehta; Anil K Sood
Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.
Cancer research 2008;68(14):5849-58.
2008: Hui Guan; Zhichao Zhou; Gary E Gallick; Shu-Fang Jia; Jaime Morales; Anil K Sood; Seth J Corey; Eugenie S Kleinerman
Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma.
Molecular cancer therapeutics 2008;7(7):1807-16.
2008: Anil K Sood; Michael J Birrer
Highlights from the 2008 Annual Meeting of the American Association for Cancer Research.
Gynecologic oncology 2008;110(1):5-6.
2008: Chunhua Lu; Mian Shahzad; Hua Wang; Charles N Landen; Seung W Kim; Julie Allen; Alpa M Nick; Nicholas B Jennings; Michael S Kinch; Menashe Bar-Eli; Anil K Sood
EphA2 overexpression promotes ovarian cancer growth.
Cancer biology & therapy 2008;7(7):1098-103.
2008: Liz Y Han; Mavis S Fletcher; Diana L Urbauer; Peter Mueller; Charles N Landen; Aparna A Kamat; Yvonne G Lin; William M Merritt; Whitney A Spannuth; Michael T Deavers; Koen De Geest; David M Gershenson; Susan K Lutgendorf; Soldano Ferrone; Anil K Sood
HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3372-9.
2008: Premal H Thaker; Anil K Sood
Neuroendocrine influences on cancer biology.
Seminars in cancer biology 2008;18(3):164-70.
2008: Amit Verma; Sushovan Guha; Parmeswaran Diagaradjane; Ajaikumar Kunnumakkara; Angela M Sanguino; Gabriel Lopez-Berestein; Anil K Sood; Bharat B Aggarwal; Sunil Krishnan; Juri G Gelovani; Kapil Mehta
Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(8):2476-83.
2008: Chunhua Lu; Premal H Thaker; Yvonne G Lin; Whitney A Spannuth; Charles N Landen; William M Merritt; Nicholas B Jennings; Robert R Langley; David M Gershenson; George D Yancopoulos; Lee M Ellis; Robert B Jaffe; Robert L Coleman; Anil K Sood
Impact of vessel maturation on antiangiogenic therapy in ovarian cancer.
American journal of obstetrics and gynecology 2008;198(4):477.e1-9; discussion 477.e9-10.
2008: Whitney A Spannuth; Anil K Sood; Robert L Coleman
Angiogenesis as a strategic target for ovarian cancer therapy.
Nature clinical practice. Oncology 2008;5(4):194-204.
2008: William M Merritt; Yvonne G Lin; Whitney A Spannuth; Mavis S Fletcher; Aparna A Kamat; Liz Y Han; Charles N Landen; Nicholas Jennings; Koen De Geest; Robert R Langley; Gabriel Villares; Angela M Sanguino; Susan K Lutgendorf; Gabriel Lopez-Berestein; Menashe M Bar-Eli; Anil K Sood
Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth.
Journal of the National Cancer Institute 2008;100(5):359-72.
2008: Angela M Sanguino; Gabriel Lopez-Berestein; Anil K Sood
Strategies for in vivo siRNA delivery in cancer.
Mini reviews in medicinal chemistry 2008;8(3):248-55.
2008: Charles N Landen; Michael J Birrer; Anil K Sood
Early events in the pathogenesis of epithelial ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):995-1005.
2008: Michael J Gray; George van Buren; Nikolaos A Dallas; Ling Xia; Xuemei Wang; Anthony D Yang; Ray Somcio; Yvonne G Lin; Sherry Lim; Fan Fan; Lingegowda S Mangala; Thiruvengadam Arumugam; Craig D Logsdon; Gabriel Lopez-Berestein; Anil K Sood; Lee M Ellis
Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
Journal of the National Cancer Institute 2008;100(2):109-20.
2008: Michael P Stany; Tomas Bonome; Fred Wamunyokoli; Kristen Zorn; Laurent Ozbun; Dong-Choon Park; Ke Hao; Jeff Boyd; Anil K Sood; David M Gershenson; Ross S Berkowitz; Samuel C Mok; Michael J Birrer
Classification of ovarian cancer: a genomic analysis.
Advances in experimental medicine and biology 2008;622():23-33.
2008: Donald M Lamkin; Susan K Lutgendorf; Stephanie McGinn; Minh Dao; Heena Maiseri; Koen DeGeest; Anil K Sood; David M Lubaroff
Positive psychosocial factors and NKT cells in ovarian cancer patients.
Brain, behavior, and immunity 2008;22(1):65-73.
2007: Aparna A Kamat; William M Merritt; Donna Coffey; Yvonne G Lin; Pooja R Patel; Russell R Broaddus; Elizabeth Nugent; Liz Y Han; Charles N Landen; Whitney A Spannuth; Chunhua Lu; Robert L Coleman; David M Gershenson; Anil K Sood
Clinical and biological significance of vascular endothelial growth factor in endometrial cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(24):7487-95.
2007: Ariel Fernández; Angela M Sanguino; Zhenghong Peng; Eylem Ozturk; Jianping Chen; Alejandro Crespo; Sarah Wulf; Aleksander Shavrin; Chaoping Qin; Jianpeng Ma; Jonathan Trent; Yvonne Lin; Hee-Dong Han; Lingegowda S Mangala; James Bankson; Juri G Gelovani; Allen Samarel; William G Bornmann; Anil K Sood; Gabriel Lopez-Berestein
An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic.
The Journal of clinical investigation 2007;117(12):4044-54.
2007: Jyotsnabaran Halder; Yvonne G Lin; William M Merritt; Whitney A Spannuth; Alpa M Nick; Toshiyuki Honda; Aparna A Kamat; Liz Y Han; Tae Jin Kim; Chunhua Lu; Ana M Tari; William G Bornmann; Ariel Fernandez; Gabriel Lopez-Berestein; Anil K Sood
Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma.
Cancer research 2007;67(22):10976-83.
2007: Charles N Landen; Yvonne G Lin; Guillermo N Armaiz-Pena; Pamela D Das; Jesusa M Arevalo; Aparna A Kamat; Liz Y Han; Nicholas B Jennings; Whitney A Spannuth; Premal H Thaker; Susan K Lutgendorf; Cherylyn A Savary; Angela M Sanguino; Gabriel Lopez-Berestein; Steve W Cole; Anil K Sood
Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer.
Cancer research 2007;67(21):10389-96.
2007: Monique B Nilsson; Guillermo N Armaiz-Pena; Rie Takahashi; Yvonne G Lin; Jose G Trevino; Yang Li; Nicholas B Jennings; Jesusa Arevalo; Susan K Lutgendorf; Gary E Gallick; Angela M Sanguino; Gabriel Lopez-Berestein; Steve W Cole; Anil K Sood
Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism.
The Journal of biological chemistry 2007;282(41):29919-26.
2007: Tae Jin Kim; Murali Ravoori; Charles N Landen; Aparna A Kamat; Liz Y Han; Chunhua Lu; Yvonne G Lin; William M Merritt; Nicholas B Jennings; Whitney A Spannuth; Robert Langley; David M Gershenson; Robert L Coleman; Vikas Kundra; Anil K Sood
Antitumor and antivascular effects of AVE8062 in ovarian carcinoma.
Cancer research 2007;67(19):9337-45.
2007: Chunhua Lu; Aparna A Kamat; Yvonne G Lin; William M Merritt; Charles N Landen; Tae Jin Kim; Whitney A Spannuth; Thiruvengadam Arumugam; Liz Y Han; Nicholas B Jennings; Craig D Logsdon; Robert B Jaffe; Robert L Coleman; Anil K Sood
Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(14):4209-17.
2007: Charles N Landen; Yvonne G Lin; Anand Immaneni; Michael T Deavers; William M Merritt; Whitney A Spannuth; Diane C Bodurka; David M Gershenson; William R Brinkley; Anil K Sood
Overexpression of the centrosomal protein Aurora-A kinase is associated with poor prognosis in epithelial ovarian cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(14):4098-104.
2007: Yvonne G Lin; Ajaikumar Kunnumakkara; Asha Nair; William M Merritt; Liz Y Han; Guillermo N Armaiz-Pena; Aparna A Kamat; Whitney A Spannuth; David M Gershenson; Susan K Lutgendorf; Bharat B Aggarwal; Anil K Sood
Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(11):3423-30.
2007: S Ram Kumar; Rizwan Masood; Whitney A Spannuth; Jasbir Singh; Jeffrey Scehnet; G Kleiber; Nicholas B Jennings; M Deavers; Valery Krasnoperov; Louis Dubeau; Fred A Weaver; Anil K Sood; parkash Gill
The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome.
British journal of cancer 2007;96(7):1083-91.
2007: Whitney A Spannuth; Premal H Thaker; Anil K Sood
Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish woman with primary breast and ovarian cancer.
American journal of obstetrics and gynecology 2007;196(4):e6-9.
2007: Michael R Milam; Anil K Sood; Sara King; Roland L Bassett; Karen H Lu; Brian M Slomovitz; Robert L Coleman; Pedro T Ramirez
Supracervical hysterectomy in patients with advanced epithelial ovarian cancer.
Obstetrics and gynecology 2007;109(3):641-6.
2007: Michael Frumovitz; Anil K Sood
Vascular endothelial growth factor (VEGF) pathway as a therapeutic target in gynecologic malignancies.
Gynecologic oncology 2007;104(3):768-78.
2007: Premal H Thaker; Susan K Lutgendorf; Anil K Sood
The neuroendocrine impact of chronic stress on cancer.
Cell cycle (Georgetown, Tex.) 2007;6(4):430-3.
2007: Chunhua Lu; Tomas Bonome; Yang Li; Aparna A Kamat; Liz Y Han; Rosemarie Schmandt; Robert L Coleman; David M Gershenson; Robert B Jaffe; Michael J Birrer; Anil K Sood
Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma.
Cancer research 2007;67(4):1757-68.
2007: Yvonne G Lin; Liz Y Han; Aparna A Kamat; William M Merritt; Charles N Landen; Michael T Deavers; Mavis S Fletcher; Diana L Urbauer; Michael S Kinch; Anil K Sood
EphA2 overexpression is associated with angiogenesis in ovarian cancer.
Cancer 2007;109(2):332-40.
2007: William M Merritt; Anil K Sood
Markers of angiogenesis in ovarian cancer.
Disease markers 2007;23(5-6):419-31.
2007: Aparna A Kamat; Tae Jin Kim; Charles N Landen; Chunhua Lu; Liz Y Han; Yvonne G Lin; William M Merritt; Premal H Thaker; David M Gershenson; Farideh Z Bischoff; John V Heymach; Robert B Jaffe; Robert L Coleman; Anil K Sood
Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer.
Cancer research 2007;67(1):281-8.
2006: Charles N Landen; William M Merritt; Lingegowda S Mangala; Angela M Sanguino; Corazon D Bucana; Chunhua Lu; Yvonne G Lin; Liz Y Han; Aparna A Kamat; Rosemarie Schmandt; Robert L Coleman; David M Gershenson; Gabriel Lopez-Berestein; Anil K Sood
Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancer.
Cancer biology & therapy 2006;5(12):1708-13.
2006: Charles N Landen; Chunhua Lu; Liz Y Han; Karen Coffman; Elizabeth M Bruckheimer; Jyotsnabaran Halder; Lingegowda S Mangala; William M Merritt; Yvonne G Lin; Changshou Gao; Rosemarie Schmandt; Aparna A Kamat; Yang Li; Premal H Thaker; David M Gershenson; Nila U Parikh; Gary E Gallick; Michael S Kinch; Anil K Sood
Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.
Journal of the National Cancer Institute 2006;98(21):1558-70.
2006: Robert L Coleman; Anil K Sood
Historical progress in the initial management of ovarian cancer: intraperitoneal chemotherapy.
Current oncology reports 2006;8(6):455-64.
2006: William M Merritt; Premal H Thaker; Charles N Landen; Michael T Deavers; Mavis S Fletcher; Yvonne G Lin; Liz Y Han; Aparna A Kamat; Rosemarie Schmandt; David M Gershenson; Michael S Kinch; Anil K Sood
Analysis of EphA2 expression and mutant p53 in ovarian carcinoma.
Cancer biology & therapy 2006;5(10):1357-60.
2006: Aparna A Kamat; Farideh Z Bischoff; Dianne X Dang; Matthew F Baldwin; Liz Y Han; Yvonne G Lin; William M Merritt; Charles N Landen; Chunhua Lu; David M Gershenson; Joe Simpson; Anil K Sood
Circulating cell-free DNA: a novel biomarker for response to therapy in ovarian carcinoma.
Cancer biology & therapy 2006;5(10):1369-74.
2006: Aparna A Kamat; Anil K Sood; Dianne X Dang; David M Gershenson; Joe Simpson; Farideh Z Bischoff
Quantification of total plasma cell-free DNA in ovarian cancer using real-time PCR.
Annals of the New York Academy of Sciences 2006;1075():230-4.
2006: Liz Y Han; Charles N Landen; Jose G Trevino; Jyotsnabaran Halder; Yvonne G Lin; Aparna A Kamat; Tae-Jin Kim; William M Merritt; Robert L Coleman; David M Gershenson; William C Shakespeare; Yihan Wang; Raji Sundaramoorth; Chester A Metcalf; David C Dalgarno; Tomi K Sawyer; Gary E Gallick; Anil K Sood
Antiangiogenic and antitumor effects of SRC inhibition in ovarian carcinoma.
Cancer research 2006;66(17):8633-9.
2006: Rosemarie Schmandt; Marsha Bennett; Stephanie Clifford; Angela Thornton; Feng Jiang; Russell R Broaddus; Charlotte C Sun; Karen H Lu; Anil K Sood; David M Gershenson
The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary.
Cancer biology & therapy 2006;5(9):1136-41.
2006: Jyotsnabaran Halder; Aparna A Kamat; Charles N Landen; Liz Y Han; Susan K Lutgendorf; Yvonne G Lin; William M Merritt; Nicholas B Jennings; Arturo Chavez-Reyes; Robert L Coleman; David M Gershenson; Rosemarie Schmandt; Steve W Cole; Gabriel Lopez-Berestein; Anil K Sood
Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(16):4916-24.
2006: David M Gershenson; Charlotte C Sun; Karen H Lu; Robert L Coleman; Anil K Sood; Anais Malpica; Michael T Deavers; Elvio G Silva; Diane C Bodurka
Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary.
Obstetrics and gynecology 2006;108(2):361-8.
2006: Premal H Thaker; Liz Y Han; Aparna A Kamat; Jesusa M Arevalo; Rie Takahashi; Chunhua Lu; Nicholas B Jennings; Guillermo N Armaiz-Pena; James Bankson; Murali Ravoori; William M Merritt; Yvonne G Lin; Lingegowda S Mangala; Tae Jin Kim; Robert L Coleman; Charles N Landen; Yang Li; Edward Felix; Angela M Sanguino; Robert A Newman; Mary Lloyd; David M Gershenson; Vikas Kundra; Gabriel Lopez-Berestein; Susan K Lutgendorf; Steve W Cole; Anil K Sood
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.
Nature medicine 2006;12(8):939-44.
2006: Aparna A Kamat; Mavis Fletcher; Lynn M Gruman; Peter Mueller; Adriana Lopez; Charles N Landen; Liz Han; David M Gershenson; Anil K Sood
The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(6):1707-14.
2006: Liz Y Han; Charles N Landen; Aparna A Kamat; Adriana Lopez; David P Bender; Peter Mueller; Rosemarie Schmandt; David M Gershenson; Anil K Sood
Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(5):755-61.
2006: Anil K Sood; Robert Bhatty; Aparna A Kamat; Charles N Landen; Liz Han; Premal H Thaker; Yang Li; David M Gershenson; Susan K Lutgendorf; Steve W Cole
Stress hormone-mediated invasion of ovarian cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(2):369-75.
2006: Aparna A Kamat; Shu Feng; Irina U Agoulnik; Farrah Kheradmand; Natalia Vladimirovna Bogatcheva; Donna Coffey; Anil K Sood; Alexander I Agoulnik
The role of relaxin in endometrial cancer.
Cancer biology & therapy 2006;5(1):71-7.
2005: Jyotsnabaran Halder; Charles N Landen; Susan K Lutgendorf; Yang Li; Nicholas B Jennings; Dominic Fan; Gina M Nelkin; Rosemarie Schmandt; Michael D Schaller; Anil K Sood
Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(24 Pt 1):8829-36.
2005: Paige Green McDonald; Michael H Antoni; Susan K Lutgendorf; Steve W Cole; Firdaus S Dhabhar; Sandra E Sephton; Michael Stefanek; Anil K Sood
A biobehavioral perspective of tumor biology.
Discovery medicine 2005;5(30):520-6.
2005: Charles N Landen; Michael S Kinch; Anil K Sood
EphA2 as a target for ovarian cancer therapy.
Expert opinion on therapeutic targets 2005;9(6):1179-87.
2005: Tomas Bonome; Ji-Young Lee; Dong-Choon Park; Michael F Radonovich; Cynthia A Pise-Masison; John Brady; Ginger J Gardner; Ke Hao; Wing H Wong; J Carl Barrett; Karen H Lu; Anil K Sood; David M Gershenson; Samuel C Mok; Michael J Birrer
Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.
Cancer research 2005;65(22):10602-12.
2005: Aparna A Kamat; Anil K Sood
The merits of vascular targeting for gynecologic malignancies.
Current oncology reports 2005;7(6):444-50.
2005: Susan K Lutgendorf; Anil K Sood; Barrie Anderson; Stephanie McGinn; Heena Maiseri; Minh Dao; Joel I Sorosky; Koen De Geest; Justine Ritchie; David M Lubaroff
Social support, psychological distress, and natural killer cell activity in ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7105-13.
2005: Charles N Landen; Arturo Chavez-Reyes; Corazon D Bucana; Rosemarie Schmandt; Michael T Deavers; Gabriel Lopez-Berestein; Anil K Sood
Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.
Cancer research 2005;65(15):6910-8.
2005: Erin S Costanzo; Susan K Lutgendorf; Anil K Sood; Barrie Anderson; Joel I Sorosky; David M Lubaroff
Psychosocial factors and interleukin-6 among women with advanced ovarian cancer.
Cancer 2005;104(2):305-13.
2005: Premal H Thaker; Sertac Yazici; Monique B Nilsson; Kenji Yokoi; Rachel Tsan; Junqin He; Sun-Jin Kim; Isaiah J Fidler; Anil K Sood
Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13):4923-33.
2005: Premal H Thaker; Kenji Yokoi; Nicholas B Jennings; Yang Li; robert rebhun; Dennis L Rousseau; Dominic Fan; Anil K Sood
Inhibition of experimental colon cancer metastasis by the GABA-receptor agonist nembutal.
Cancer biology & therapy 2005;4(7):753-8.
2005: Anil K Sood; Robert L Coleman; Judith K Wolf; David M Gershenson
Selected highlights from the 5th International Conference on Ovarian Cancer. Houston, TX, USA, 1-4 December 2004.
Expert opinion on pharmacotherapy 2005;6(7):1269-75.
2005: Anil K Sood; Nadeem R Abu-Rustum; Richard R Barakat; Diane C Bodurka; Jubilee Brown; Michele L Donato; Elizabeth A Poynor; Judith K Wolf; David M Gershenson
Fifth International Conference on Ovarian Cancer: challenges and opportunities.
Gynecologic oncology 2005;97(3):916-23.
2005: Navesh Sharma; Joel I Sorosky; David Bender; Mavis S Fletcher; Anil K Sood
Malignant mixed mullerian tumor (MMMT) of the cervix.
Gynecologic oncology 2005;97(2):442-5.
2005: Anil K Sood; Brian C Cooper; Joel I Sorosky; Pedro T Ramirez; Charles Levenback
Novel modification of the vertical rectus abdominis myocutaneous flap for neovagina creation.
Obstetrics and gynecology 2005;105(3):514-8.
2004: Charles N Landen; Al Klingelhutz; Jeremy E Coffin; Joel I Sorosky; Anil K Sood
Genomic instability is associated with lack of telomerase activation in ovarian cancer.
Cancer biology & therapy 2004;3(12):1250-3.
2004: Anil K Sood; Jeremy E Coffin; Galen B Schneider; Mavis S Fletcher; Barry R DeYoung; Lynn M Gruman; David M Gershenson; Michael D Schaller; Mary J C Hendrix
Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion.
The American journal of pathology 2004;165(4):1087-95.
2004: Anil K Sood; Richard Lush; John P Geisler; Mark S Shahin; Linda Sanders; Dan Sullivan; Richard E Buller; Joel I Sorosky
Sequential intraperitoneal topotecan and oral etoposide chemotherapy in recurrent platinum-resistant ovarian carcinoma: results of a phase II trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(18 Pt 1):6080-5.
2004: Premal H Thaker; Michael Deavers; Joseph Celestino; Angela Thornton; Mavis S Fletcher; Charles N Landen; Michael S Kinch; Peter Kiener; Anil K Sood
EphA2 expression is associated with aggressive features in ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):5145-50.
2004: Stephen D Frausto; John P Geisler; Mavis S Fletcher; Anil K Sood
Late recurrence of juvenile granulosa cell tumor of the ovary.
American journal of obstetrics and gynecology 2004;191(1):366-7.
2004: Anil K Sood; Mavis S Fletcher; Jeremy E Coffin; Maria Yang; Elisabeth A Seftor; Lynn M Gruman; David M Gershenson; Mary J C Hendrix
Functional role of matrix metalloproteinases in ovarian tumor cell plasticity.
American journal of obstetrics and gynecology 2004;190(4):899-909.
2004: Yvonne Hsu; Anil K Sood; Joel I Sorosky
Docetaxel versus paclitaxel for adjuvant treatment of ovarian cancer: case-control analysis of toxicity.
American journal of clinical oncology 2004;27(1):14-8.
2004: Amy C Eichholz; Bradley J Van Voorhis; Joel I Sorosky; Brian J Smith; Anil K Sood
Operative note dictation: should it be taught routinely in residency programs?
Obstetrics and gynecology 2004;103(2):342-6.
2003: M Patrick Lowe; Brian C Cooper; Anil K Sood; William A Davis; Craig H Syrop; Joel I Sorosky
Implementation of assisted reproductive technologies following conservative management of FIGO grade I endometrial adenocarcinoma and/or complex hyperplasia with atypia.
Gynecologic oncology 2003;91(3):569-72.
2003: John P Geisler; Michael J Goodheart; Anil K Sood; Richard J Holmes; Melanie A Hatterman-Zogg; Richard E Buller
Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
Cancer 2003;98(10):2199-206.
2003: Susan K Lutgendorf; Steven Cole; Erin S Costanzo; Sarah Bradley; Jeremy E Coffin; Sarvenaz Jabbari; Kaitlin Rainwater; Justine M Ritchie; Maria Yang; Anil K Sood
Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(12):4514-21.
2003: Anil K Sood; Mary J C Hendrix
The complexity of tumor vascularity.
Cancer biology & therapy 2003;2(3):257-8.
2003: Mee Lee Chun; Thomas E Buekers; Anil K Sood; Joel I Sorosky
Postoperative wound infection with Pasteurella multocida from a pet cat.
American journal of obstetrics and gynecology 2003;188(4):1115-6.
2002: Anil K Sood; Mavis S Fletcher; Christopher M Zahn; Lynn M Gruman; Jeremy E Coffin; Elisabeth A Seftor; Mary J C Hendrix
The clinical significance of tumor cell-lined vasculature in ovarian carcinoma: implications for anti-vasculogenic therapy.
Cancer biology & therapy 2002;1(6):661-4.
2002: Anil K Sood; Ingrid Nygaard; Mark S Shahin; Joel I Sorosky; Susan K Lutgendorf; Satish S C Rao
Anorectal dysfunction after surgical treatment for cervical cancer.
Journal of the American College of Surgeons 2002;195(4):513-9.
2002: Brian C Cooper; Justine M Ritchie; Carrie L W Broghammer; Jeremy E Coffin; Joel I Sorosky; Richard E Buller; Mary J C Hendrix; Anil K Sood
Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(10):3193-7.
2002: Anil K Sood; Jeremy E Coffin; Sarvenaz Jabbari; Richard E Buller; Mary J C Hendrix; Al Klingelhutz
p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma.
Cancer biology & therapy 2002;1(5):511-7.
2002: Anil K Sood; Mavis S Fletcher; Lynn M Gruman; Jeremy E Coffin; Sarvenaz Jabbari; Zhila Khalkhali-Ellis; Nancy Arbour; Elisabeth A Seftor; Mary J C Hendrix
The paradoxical expression of maspin in ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(9):2924-32.
2002: Susan K Lutgendorf; Erica L Johnsen; Brian Cooper; Barrie Anderson; Joel I Sorosky; Richard E Buller; Anil K Sood
Vascular endothelial growth factor and social support in patients with ovarian carcinoma.
Cancer 2002;95(4):808-15.
2002: Brian C Cooper; Anil K Sood; Charles S Davis; Justine M Ritchie; Joel I Sorosky; Barrie Anderson; Richard E Buller
Preoperative CA 125 levels: an independent prognostic factor for epithelial ovarian cancer.
Obstetrics and gynecology 2002;100(1):59-64.
2002: Amy C Eichholz; Vikas Mahavni; Anil K Sood
Allopathic and complementary alternatives to hormone replacement therapy.
Expert opinion on pharmacotherapy 2002;3(7):949-55.
2002: Michael J Goodheart; Mohammad A Vasef; Anil K Sood; Charles S Davis; Richard E Buller
Ovarian cancer p53 mutation is associated with tumor microvessel density.
Gynecologic oncology 2002;86(1):85-90.
2002: Jeffrey D Bloss; John A Blessing; Brent C Behrens; Robert S Mannel; Janet S Rader; Anil K Sood; Maurie Markman; Jo Ann Benda
Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1832-7.
2002: Anil K Sood; Mavis S Fletcher; Mary J C Hendrix
The embryonic-like properties of aggressive human tumor cells.
Journal of the Society for Gynecologic Investigation 2002;9(1):2-9.
2002: Susan K Lutgendorf; Barrie Anderson; Philip M Ullrich; Erica L Johnsen; Richard E Buller; Anil K Sood; Joel I Sorosky; Justine Ritchie
Quality of life and mood in women with gynecologic cancer: a one year prospective study.
Cancer 2002;94(1):131-40.
2002: M Patrick Lowe; David Bender; Anil K Sood; William Davis; Craig H Syrop; Joel I Sorosky
Two successful pregnancies after conservative treatment of endometrial cancer and assisted reproduction.
Fertility and sterility 2002;77(1):188-9.
2001: Anil K Sood; Mark S Shahin; Joel I Sorosky
Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy.
Gynecologic oncology 2001;83(3):599-600.
2001: John P Geisler; Joel I Sorosky; H L Duong; Thomas E Buekers; M J Geisler; Anil K Sood; Barrie Anderson; Richard E Buller
Papillary serous carcinoma of the uterus: increased risk of subsequent or concurrent development of breast carcinoma.
Gynecologic oncology 2001;83(3):501-3.
2001: Vikas Mahavni; Anil K Sood
Hormone replacement therapy and cancer risk.
Current opinion in oncology 2001;13(5):384-9.
2001: Anil K Sood; R Holmes; Mary J C Hendrix; Richard E Buller
Application of the National Cancer Institute international criteria for determination of microsatellite instability in ovarian cancer.
Cancer research 2001;61(11):4371-4.
2001: Richard E Buller; TA Lallas; Mark S Shahin; Anil K Sood; Melanie A Hatterman-Zogg; B Anderson; Joel I Sorosky; PA Kirby
The p53 mutational spectrum associated with BRCA1 mutant ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(4):831-8.
2001: Richard E Buller; Mark S Shahin; R W Holmes; M Hatterman; PA Kirby; Anil K Sood
p53 Mutations and microsatellite instability in ovarian cancer: Yin and yang.
American journal of obstetrics and gynecology 2001;184(5):891-902; discussion 902-3.
2001: Anil K Sood; Elisabeth A Seftor; Mavis S Fletcher; L M G Gardner; Paul M Heidger; R E Buller; Richard E B Seftor; Mary J C Hendrix
Molecular determinants of ovarian cancer plasticity.
The American journal of pathology 2001;158(4):1279-88.
2001: M Patrick Lowe; Kevin A Ault; Anil K Sood
Recurrent carcinoma in situ of a neovagina.
Gynecologic oncology 2001;80(3):403-4.
2001: Anil K Sood; Richard E Buller
SSCP and Sequence Analysis of p53 Mutations in Ovarian Tumors.
Methods in molecular medicine 2001;39():323-8.
2000: Mark S Shahin; Jonathan H Hughes; Anil K Sood; Richard E Buller
The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma.
Cancer 2000;89(9):2006-17.
2000: V A Minassian; Anil K Sood; P Lowe; Joel I Sorosky; Adel S Al-Jurf; Richard E Buller
Longterm central venous access in gynecologic cancer patients.
Journal of the American College of Surgeons 2000;191(4):403-9.
2000: S H Zhang; Anil K Sood; Joel I Sorosky; Barrie Anderson; Richard E Buller
Preservation of the saphenous vein during inguinal lymphadenectomy decreases morbidity in patients with carcinoma of the vulva.
Cancer 2000;89(7):1520-5.
2000: Susan K Lutgendorf; Barrie Anderson; Nan E Rothrock; Richard E Buller; Anil K Sood; Joel I Sorosky
Quality of life and mood in women receiving extensive chemotherapy for gynecologic cancer.
Cancer 2000;89(6):1402-11.
2000: Anil K Sood; Joel I Sorosky; Nina A Mayr; Barrie Anderson; Richard E Buller; Jennifer R Niebyl
Cervical cancer diagnosed shortly after pregnancy: prognostic variables and delivery routes.
Obstetrics and gynecology 2000;95(6 Pt 1):832-8.
2000: S Pertzborn; Thomas E Buekers; Anil K Sood
Hematogenous skin metastases from cervical cancer at primary presentation.
Gynecologic oncology 2000;76(3):416-7.
1999: Anil K Sood; Joel I Sorosky; M Dolan; B Anderson; Richard E Buller
Distant metastases in ovarian cancer: association with p53 mutations.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(9):2485-90.
1999: Anil K Sood; Joel I Sorosky; R C Squatrito; JS Skilling; Barrie Anderson; Richard E Buller
Cyclosporin A reverses chemoresistance in patients with gynecologic malignancies.
Neoplasia (New York, N.Y.) 1999;1(2):118-22.
1999: Richard E Buller; Anil K Sood; TA Lallas; Thomas E Buekers; JS Skilling
Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer.
Journal of the National Cancer Institute 1999;91(4):339-46.
1998: Anil K Sood; Richard E Buller
Drug resistance in ovarian cancer: from the laboratory to the clinic.
Obstetrics and gynecology 1998;92(2):312-9.
1998: Anil K Sood; Joel I Sorosky
Invasive cervical cancer complicating pregnancy. How to manage the dilemma.
Obstetrics and gynecology clinics of North America 1998;25(2):343-52.
1998: Anil K Sood; Joel I Sorosky; M S Gelder; Richard E Buller; Barrie Anderson; Edward J Wilkinson; Jo Ann Benda; L S Morgan
Primary ovarian sarcoma: analysis of prognostic variables and the role of surgical cytoreduction.
Cancer 1998;82(9):1731-7.
1998: Richard E Buller; JS Skilling; Anil K Sood; S Plaxe; R N Baergen; Donna J Lager
Field cancerization: why late "recurrent" ovarian cancer is not recurrent.
American journal of obstetrics and gynecology 1998;178(4):641-9.
1998: C C Signore; Anil K Sood; DS Richards
Second-trimester vaginal bleeding: correlation of ultrasonographic findings with perinatal outcome.
American journal of obstetrics and gynecology 1998;178(2):336-40.
1998: J K Olson; Anil K Sood; Joel I Sorosky; Barrie Anderson; Richard E Buller
Taxol hypersensitivity: rapid retreatment is safe and cost effective.
Gynecologic oncology 1998;68(1):25-8.
1997: Anil K Sood; Joel I Sorosky; Nina A Mayr; S Krogman; Barrie Anderson; Richard E Buller; David H Hussey
Radiotherapeutic management of cervical carcinoma that complicates pregnancy.
Cancer 1997;80(6):1073-8.
1997: Anil K Sood; Richard E Buller; Robert A Burger; Jeffrey D Dawson; Joel I Sorosky; M Berman
Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome.
Obstetrics and gynecology 1997;90(3):441-7.
1997: Joel I Sorosky; Anil K Sood; Thomas E Buekers
The use of chemotherapeutic agents during pregnancy.
Obstetrics and gynecology clinics of North America 1997;24(3):591-9.
1997: C C Rasmussen; Anil K Sood; Joel I Sorosky; Barrie Anderson
Posterior exenteration through groin incision in a patient with stage III vulvar carcinoma.
Gynecologic oncology 1997;66(2):331-4.
1997: Anil K Sood; JS Skilling; Richard E Buller
Ovarian cancer genomic instability correlates with p53 frameshift mutations.
Cancer research 1997;57(6):1047-9.
1996: Anil K Sood; Joel I Sorosky; S Krogman; Barrie Anderson; Jo Ann Benda; Richard E Buller
Surgical management of cervical cancer complicating pregnancy: a case-control study.
Gynecologic oncology 1996;63(3):294-8.
1995: Anil K Sood; Michael K Yancey; D Richards
Prediction of fetal macrosomia using humeral soft tissue thickness.
Obstetrics and gynecology 1995;85(6):937-40.
1995: Anil K Sood; M S Gelder; S W Huang; Linda S Morgan
Anaphylaxis to carboplatin following multiple previous uncomplicated courses.
Gynecologic oncology 1995;57(1):131-2.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.